Shandong Sino-Agri United Biotechnology Co Ltd (003042) - Total Liabilities
Based on the latest financial reports, Shandong Sino-Agri United Biotechnology Co Ltd (003042) has total liabilities worth CN¥2.71 Billion CNY (≈ $396.58 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shandong Sino-Agri United Biotechnology Co Ltd - Total Liabilities Trend (2015–2025)
This chart illustrates how Shandong Sino-Agri United Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 003042 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Shandong Sino-Agri United Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Sino-Agri United Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bhansali Engineering Polymers Limited
NSE:BEPL
|
India | Rs2.02 Billion |
|
Akebia Ther
NASDAQ:AKBA
|
USA | $343.95 Million |
|
Highlight Tech
TWO:6208
|
Taiwan | NT$3.84 Billion |
|
Sampo Corp
TW:1604
|
Taiwan | NT$9.80 Billion |
|
Atha Energy Corp.
V:SASK
|
Canada | CA$10.30 Million |
|
QST International
TWO:8349
|
Taiwan | NT$14.47 Billion |
|
XiAn Qujiang Cultural Tourism Co Ltd
SHG:600706
|
China | CN¥2.13 Billion |
|
Nexpoint Real Estate Finance Inc
NYSE:NREF
|
USA | $4.49 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Shandong Sino-Agri United Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Sino-Agri United Biotechnology stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Sino-Agri United Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Sino-Agri United Biotechnology Co Ltd (2015–2025)
The table below shows the annual total liabilities of Shandong Sino-Agri United Biotechnology Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.60 Billion ≈ $380.86 Million |
+0.92% |
| 2024-12-31 | CN¥2.58 Billion ≈ $377.39 Million |
+13.64% |
| 2023-12-31 | CN¥2.27 Billion ≈ $332.10 Million |
+22.17% |
| 2022-12-31 | CN¥1.86 Billion ≈ $271.83 Million |
+16.56% |
| 2021-12-31 | CN¥1.59 Billion ≈ $233.20 Million |
+22.18% |
| 2020-12-31 | CN¥1.30 Billion ≈ $190.86 Million |
+34.12% |
| 2019-12-31 | CN¥972.46 Million ≈ $142.30 Million |
-1.74% |
| 2018-12-31 | CN¥989.66 Million ≈ $144.82 Million |
-16.56% |
| 2017-12-31 | CN¥1.19 Billion ≈ $173.56 Million |
+28.63% |
| 2016-12-31 | CN¥922.05 Million ≈ $134.92 Million |
+17.25% |
| 2015-12-31 | CN¥786.42 Million ≈ $115.08 Million |
-- |
About Shandong Sino-Agri United Biotechnology Co Ltd
Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. The company's products include imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. It also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States.… Read more